The challenging task of enumerating blasts in the bone marrow

Greenberg, 2017, Myelodysplastic syndromes, Version 2.2017, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 15, 60, 10.6004/jnccn.2017.0007 Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544 Greenberg, 2012, Revised international prognostic scoring system for myelodysplastic syndromes, Blood, 120, 2454, 10.1182/blood-2012-03-420489 Font, 2015, Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts, Ann Hematol, 94, 565, 10.1007/s00277-014-2252-4 Font, 2013, Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification, Ann Hematol, 92, 19, 10.1007/s00277-012-1565-4 Naqvi, 2011, Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers, Blood, 118, 4690, 10.1182/blood-2011-03-342642 Senent, 2013, Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes, Haematologica, 98, 568, 10.3324/haematol.2012.071449 Loken, 2009, Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses, Cytometry B Clin Cytom, 76, 27, 10.1002/cyto.b.20429 Kanter-Lewensohn, 1996, Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry, Eur J Haematol, 56, 124, 10.1111/j.1600-0609.1996.tb01330.x Baur, 2000, CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes, Eur J Haematol, 64, 71, 10.1034/j.1600-0609.2000.90047.x Min, 1995, CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes, Yonsei Med J, 36, 1, 10.3349/ymj.1995.36.1.1 Torlakovic, 2002, CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes, Arch Pathol Lab Med, 126, 823, 10.5858/2002-126-0823-CQIITB Horny, 1995, QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens, J Clin Pathol, 48, 291, 10.1136/jcp.48.4.291 Oriani, 1996, Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes, Br J Haematol, 92, 360, 10.1046/j.1365-2141.1996.d01-1484.x Soligo, 1991, Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody, Leukemia, 5, 1026 Vardiman, 2009, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, 114, 937, 10.1182/blood-2009-03-209262 McGowan-Jordan, 2016 2017 Bland, 2007, Agreement between methods of measurement with multiple observations per individual, J Biopharm Stat, 17, 571, 10.1080/10543400701329422 Shrout, 1979, Intraclass correlations: uses in assessing rater reliability, Psychol Bull, 86, 420, 10.1037/0033-2909.86.2.420 Cicchetti, 1981, Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior, Am J Ment Defic, 86, 127 Schanz, 2012, New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge, J Clin Oncol, 30, 820, 10.1200/JCO.2011.35.6394 Swerdlow, 2017, Vol 2 Dresch, 1974, The cellular composition of the granulocyte series in the normal human bone marrow according to the volume of the sample, J Clin Pathol, 27, 106, 10.1136/jcp.27.2.106 Batinic, 1990, Relationship between differing volumes of bone marrow aspirates and their cellular composition, Bone Marrow Transplant, 6, 103 Bennett, 2016, Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?), Leuk Res, 47, 63, 10.1016/j.leukres.2016.05.006 Zeidan, 2017, The importance of erythroblast enumeration in myeloid neoplasia, Ann Hematol, 96, 329, 10.1007/s00277-016-2862-0 Calvo, 2017, Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R), Am J Hematol, 92, 614, 10.1002/ajh.24732